ABOS
Acumen Pharmaceuticals Inc
NASDAQ: ABOS · HEALTHCARE · BIOTECHNOLOGY
$2.34
-4.88% today
Updated 2026-04-29
Market cap
$169.01M
P/E ratio
—
P/S ratio
538.78x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$1 – $4
Volume
0.6M
Acumen Pharmaceuticals Inc (ABOS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-96.20%
ROA
-42.80%
Debt/equity
0.33x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $1.70M | $-7.91M | -405.36% | -459.93% | -465.94% |
| 2020 | $1.44M | $-7.33M | -456.89% | -550.97% | -510.10% |
| 2021 | $1.44M | $-100.61M | -856.89% | -1,363.79% | -7,005.99% |
| 2022 | $0.00 | $-42.86M | — | — | — |
| 2023 | $0.00 | $-52.37M | — | — | — |
| 2024 | $0.00 | $-102.33M | — | — | — |
| 2025 | $0.00 | $-121.33M | — | — | — |